Cargando…
Comparative Pharmacokinetics and Tissue Distribution of M10 and Its Metabolite Myricetin in Normal and Dextran-Sodium-Sulfate-Induced Colitis Mice
M10, a novel myricetin derivative, is an anti-inflammatory agent designed for treatment of colitis. Here, we aim to investigate its pharmacokinetic behavior and tissue distribution in a mouse model with colitis. Pharmacokinetics and tissue distribution of M10 and its metabolite myricetin were compar...
Autores principales: | Zhao, Jianchun, Yuan, Wenmin, Wang, Shixiao, Zhang, Hongwei, Chen, Dan, Niu, Xiaochen, Liu, Xiaochun, Liu, Li, Gao, Jiangming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740244/ https://www.ncbi.nlm.nih.gov/pubmed/36500233 http://dx.doi.org/10.3390/molecules27238140 |
Ejemplares similares
-
Differential analysis of intestinal microbiota and metabolites in mice with dextran sulfate sodium-induced colitis
por: Wang, Jia-Li, et al.
Publicado: (2022) -
Alloferon Alleviates Dextran Sulfate Sodium-induced Colitis
por: Kim, Hyemin, et al.
Publicado: (2015) -
Calycosin attenuates dextran sulfate sodium (DSS)-induced experimental colitis
por: Chao, Liu, et al.
Publicado: (2017) -
Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)
por: Whittem, Caitlyn G., et al.
Publicado: (2010) -
Baicalein Inhibits Dextran Sulfate Sodium-induced Mouse Colitis
por: Zhong, Xiancai, et al.
Publicado: (2019)